Sol-Gel Technologies (SLGL) Other financing activities (2018 - 2023)
Sol-Gel Technologies (SLGL) posted quarterly Other financing activities of $1.2 million for Q2 2023, up 1.48% year-over-year from $1.2 million in Q2 2022, and up 1.48% quarter-over-quarter from $1.2 million in Q2 2022.
Sol-Gel Technologies (SLGL) Other financing activities (2018 - 2023) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Other financing activities for 6 consecutive years, with $1.2 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Other financing activities rose 1.48% year-over-year to $1.2 million; the TTM figure through Jun 2023 stood at $4.6 million (up 48.31% YoY), while the FY2025 annual figure was $6000.0, changed N/A from the prior year.
- Other financing activities grew to $1.2 million in Q2 2023 per SLGL's latest filing, from $1.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $1.2 million in Q2 2023 and bottomed at -$337000.0 in Q4 2019.
- Historically, Other financing activities has averaged $856000.0 across 5 years, with a median of $1.2 million in 2020.
- Annual changes were most pronounced in 2021 — Other financing activities changed 0.0% — and 2023, when it gained 1.48%.
- Sol-Gel Technologies' Other financing activities stood at -$337000.0 in 2019, then soared by 441.25% to $1.2 million in 2020, then changed by 0.0% to $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then increased by 1.48% to $1.2 million in 2023.
- Business Quant data shows SLGL's Other financing activities at $1.2 million in Q2 2023, $1.2 million in Q2 2022, and $1.2 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Dec 31, 2019 | -337,000.00 |
| Dec 31, 2019 | -337,000.00 |
| Jun 30, 2018 | 350,000.00 |
| Jun 30, 2018 | 350,000.00 |